| Name | DBPR112 |
|---|
| Description | DBPR112 (compound 78) is an orally active Furanopyrimidine-Based Epidermal Growth Factor Receptor inhibitor with IC50s of 15 nM and 48 nM for EGFRWT and EGFRL858R/T790M, respectively. DBPR112 has significant antitumor efficacy[1]. |
|---|---|
| Related Catalog | |
| Target |
EGFRWT:15 nM (IC50) EGFRL858R/T790M:48 nM (IC50) |
| References |
| Molecular Formula | C32H31N5O3 |
|---|---|
| Molecular Weight | 533.62 |